Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants
暂无分享,去创建一个
W. Mali | E. Vonken | M. Bots | Y. van der Graaf | F. Visseren | B. Velthuis | P. Doevendans | M. Meijs | M. Cramer
[1] P. Wilson,et al. Prediction of cardiovascular disease events. , 2011, Cardiology clinics.
[2] W. Mali,et al. Differences in determinants of left ventricular mass assessed by cardiac magnetic resonance imaging across subjects with and without previous symptomatic atherosclerotic disease. , 2010, International journal of cardiology.
[3] O. Jolobe. Unrecognised myocardial infarction in subjects at high vascular risk , 2009, Heart.
[4] Salim Yusuf,et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. , 2009, American heart journal.
[5] A. Einstein. Radiation risk from coronary artery disease imaging: how do different diagnostic tests compare? , 2008, Heart.
[6] M. Hamon,et al. Should radial artery access be the “gold standard” for PCI? , 2008, Heart.
[7] R. Barriales-Villa,et al. [Pheochromocytoma-related cardiomyopathy or stress cardiomyopathy secondary to pheochromocytoma: is new terminology needed?]. , 2008, Revista espanola de cardiologia.
[8] S. Capewell,et al. Maximising secondary prevention therapies in patients with coronary heart disease , 2007, Heart.
[9] Yuh-Min Song,et al. Faculty Opinions recommendation of Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. , 2007 .
[10] Jeroen J. Bax,et al. The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery , 2007, Coronary artery disease.
[11] Lars Lind,et al. Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosis. , 2007, Radiology.
[12] G. Feder,et al. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance , 2007, Heart.
[13] D. Cook,et al. Trends in secondary prevention of ischaemic heart disease in the UK 1994–2005: use of individual and combination treatment , 2007, Heart.
[14] M. Bouvy,et al. Effect of drug combinations on admission for recurrent myocardial infarction , 2007, Heart.
[15] Y. Graaf,et al. Rationale and design of the SMART Heart study A prediction model for left ventricular hypertrophy in hypertension , 2007 .
[16] W. Mali,et al. Rationale and design of the SMART Heart study , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[17] W. Mali,et al. Left ventricular hypertrophy: a shift in paradigm. , 2007, Current medicinal chemistry.
[18] Håkan Ahlström,et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. , 2006, Journal of the American College of Cardiology.
[19] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[20] J. Sobrino,et al. Pheochromocytoma-Related Cardiomyopathy , 2006 .
[21] N. Geller,et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. , 2006, Journal of the American College of Cardiology.
[22] J. Christiansen,et al. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. , 2006, The American journal of cardiology.
[23] A. Hofman,et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. , 2006, European heart journal.
[24] H. Lange,et al. Randomized comparison of operator radiation exposure during coronary angiography and intervention by radial or femoral approach , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[25] N. Wareham,et al. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events , 2005 .
[26] N. Wareham,et al. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? , 2005, Current opinion in nephrology and hypertension.
[27] J. Debatin,et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. , 2005, AJR. American journal of roentgenology.
[28] A. Hofman,et al. The association of Rose questionnaire angina pectoris and coronary calcification in a general population: the Rotterdam Coronary Calcification Study. , 2004, Annals of epidemiology.
[29] A. Algra,et al. Second Manifestations of ARTerial disease (SMART) study: Rationale and design , 1999, European Journal of Epidemiology.
[30] Abnash C. Jain,et al. Etiologies of left bundle branch block and correlations with hemodynamic and angiographic findings. , 2003, The American journal of cardiology.
[31] Edwin Wu,et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.
[32] A. Go,et al. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain , 2000 .
[33] B. Gersh,et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. , 2000, Journal of the American College of Cardiology.
[34] W. Young,et al. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[35] L. S. Jónsdóttir,et al. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. , 1998, European heart journal.
[36] A. Hoes,et al. Prevalence, Determinants, and Misclassification of Myocardial Infarction in the Elderly , 1997, Epidemiology.
[37] R. Kim,et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.
[38] G. Thorgeirsson,et al. Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.
[39] W. L. Ooi,et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.
[40] D. Spodick,et al. The incidence and prognosis of unrecognized myocardial infarction. , 1990, Archives of internal medicine.
[41] W. Kannel,et al. Incidence, precursors and prognosis of unrecognized myocardial infarction. , 1990, Advances in cardiology.
[42] K. Yano,et al. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. , 1989, Archives of internal medicine.
[43] J. Neaton,et al. Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT) , 1987, Circulation.
[44] W. Kannel,et al. Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.
[45] A. Belanger,et al. The Framingham study. , 1976, British medical journal.
[46] J. Medalie,et al. Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. , 1976, Annals of internal medicine.
[47] C. Jenkins,et al. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. , 1967, The American journal of cardiology.
[48] R. Magno,et al. Coronary heart disease , 1957 .